BackgroundCheck.run
Search For

Gina J Chu, 83330 Avenida Sevilla UNIT A, Laguna Beach, CA 92637

Gina Chu Phones & Addresses

330 Avenida Sevilla UNIT A, Laguna Woods, CA 92637    949-4587938   

Laguna Hills, CA   

Los Angeles, CA   

Irvine, CA   

1939 S Crescent Heights Blvd, Los Angeles, CA 90034   

Mentions for Gina J Chu

Gina Chu resumes & CV records

Resumes

Gina Chu Photo 27

Gina Chu

Location:
255 south Rengstorff Ave, Mountain View, CA 94040
Industry:
Computer Software
Work:
Tsmc
Department Manager, Machine Learning Analytics and Ai Application Division
Tsmc Oct 2006 - Oct 2019
Manager, Application Development
Yahoo Sep 2003 - Oct 2006
Senior Engineer Lead
Microsoft Jun 2000 - Sep 2003
Senior Software Engineer
Oracle Mar 1996 - Jun 2000
Senior Technical Staff
Education:
Stanford University 1994 - 1996
Master of Science In Computer Science, Masters, Computer Science
National Chiao Tung University 1989 - 1993
Bachelors, Bachelor of Science, Computer Science
Skills:
Software Development, Distributed Systems, Web Applications, Scalability, Perl, Python, Software Engineering, Java, Linux
Gina Chu Photo 28

Gina Chu

Location:
Laguna Woods, CA
Industry:
Sports
Work:
Freelance
N and A
Gina Chu Photo 29

Processor

Location:
Los Angeles, CA
Industry:
Real Estate
Work:
Mk Lending Corp
Processor
Gina Chu Photo 30

Gina Chu

Gina Chu Photo 31

Student

Gina Chu Photo 32

Geo Corp, Direct Lender

Position:
Mortgage Lending at Geo Corp
Location:
Greater Los Angeles Area
Industry:
Real Estate
Work:
Geo Corp since Apr 2011
Mortgage Lending
Education:
University of Hawaii - College of Business Administration 1994 - 1997

Publications & IP owners

Us Patents

Compounds And Methods To Sensitize Cancer Cells To Tyrosine Kinase Inhibitors

US Patent:
2019026, Sep 5, 2019
Filed:
Oct 21, 2017
Appl. No.:
16/343645
Inventors:
- Los Angeles CA, US
- Beverly Hills CA, US
Stefan Mrdenovic - Osijek, HR
Gina Chi-Yi Chu - Los Angeles CA, US
Ruoxiang Wang - Los Angeles CA, US
Qinghua Zhou - Chengdu (Sichuan province), CN
Jian Zhang - Ann Arbor MI, US
Leland W. K. Chung - Beverly Hills CA, US
International Classification:
A61K 47/54
A61K 31/366
A61K 33/243
A61K 31/5377
A61K 31/519
A61K 31/357
A61K 31/65
A61P 35/00
A61P 35/04
Abstract:
The present invention generally relates to sensitizer compounds and their use in combination with Tyrosine Kinase Inhibitors (TKIs) for sensitizing tumor, cancer or pre-cancerous cells to TKI treatment. In particular, the present invention relates to administration regimes that combine TKIs such as Gefitinib or Icotinib with TKI-sensitizing DZ1 esters and amides conjugated to statin or platin-based drugs, or to Artemisinin, including, without limitation: DZ1-Simvastatin amide, DZ1-Simvastatin ester, DZ1-Cisplatin ester, and DZ1-Cisplatin amide, DZ1-Artemisinin ester, and DZ1-Artemisinin amide. Furthermore, the present invention relates to improved TKI treatment of cancers by sensitizing tumor, cancer or pre-cancerous cells, in particular cancers that develop TKI resistance, including e.g. lung cancer and pancreatic cancer.

Simvastatin And Chemotherapeutic Conjugates With A Heptamethine Carbocyanine Dye Resensitize Human Tumors To Hormonal Antagonists And Chemotherapy

US Patent:
2019026, Sep 5, 2019
Filed:
Oct 21, 2017
Appl. No.:
16/343732
Inventors:
- Los Angeles CA, US
Stefan Mrdenovic - Osijek, HR
Yi Zhang - Los Angeles CA, US
Gina Chi-Yi Chu - Los Angeles CA, US
Ruoxiang Wang - Los Angeles CA, US
Frank N. Chang - Dresher PA, US
George Paul Tuszynski - Pittsgrove NJ, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 49/00
A61P 35/00
A61K 31/22
A61K 31/282
A61K 31/337
A61K 31/366
A61K 31/4045
A61K 31/47
A61K 31/505
A61K 31/555
A61K 31/704
A61K 33/243
A61K 31/7068
A61K 47/52
A61K 47/55
Abstract:
This application relates to dye-therapeutic moiety conjugates for imaging, targeting, and treating cancerous cells and/or tumors.

Compounds And Methods To Sensitize Cancer Cells To Cisplatin

US Patent:
2019026, Aug 29, 2019
Filed:
Oct 21, 2017
Appl. No.:
16/343697
Inventors:
- Los Angeles CA, US
- Beverly Hills CA, US
Stefan Mrdenovic - Osijek, HR
Gina Chi-Yi Chu - Los Angeles CA, US
Ruoxiang Wang - Los Angeles CA, US
Qinghua Zhou - Chengdu (Sichuan province), CN
Jian Zhang - Ann Arbor MI, US
Leland W. K. Chung - Beverly Hills CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
DA ZEN THERANOSTICS, INC. - Beverly Hills CA
International Classification:
A61K 31/404
A61K 31/282
A61P 35/00
A61K 31/366
A61K 31/513
A61K 31/351
A61K 31/337
A61K 31/47
A61K 31/22
Abstract:
The present invention generally relates to sensitizer compounds and their use to sensitize cancer and/or pre-cancerous cells of certain cancers to treatment with certain resistance-prone therapeutics used in cancer therapy. In embodiments, the conjugates of particular esters or amides of Near Infrared Dyes, are used as sensitizers to avoid or overcome therapeutic resistance once formed. In embodiments, the sensitizers include conjugates with Cisplatin, Simvastatin, Artemisinin, platin-based compounds or statins. In embodiments, the resistance prone cancer therapeutics include cisplatin, gemcitabine, doxorubicin, paclitaxel, docetaxel, and platin-based compounds. These may be administered in combination with the sensitizer, or the sensitizer itself may comprise an therapeutic-derived moiety conjugated to the sensitizer, for example as is the case for dye-CIS conjugated sensitizers. Alternatively, the sensitizer may be co-administered with one or more therapeutic. Embodiments of the invention may advantageously be used in cancers that have a tendency to develop resistance to such cancer therapeutics and/or to form metastases, including e.g. lung, pancreatic, prostate, testicular, ovarian, cervical, bladder, breast, head and neck, esophageal, and stomach, cancers, germ cell tumors, lymphomas and other cancers.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.